您的当前位置:首页 > 行业数据 > 一线CLL/SLL持续治疗方案III期临床数据(非头对头对比):泽布替尼展现同类最优潜力
图片属性
图片格式:PNG 图片大小:852KB 图片尺寸:2346*1451
同报告图片
 / 4
一线CLL/SLL持续治疗方案III期临床数据(非头对头对比):泽布替尼展现同类最优潜力_第1页
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
一线CLL/SLL持续治疗方案III期临床数据(非头对头对比):泽布替尼展现同类最优潜力_第2页
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
一线CLL/SLL持续治疗方案III期临床数据(非头对头对比):泽布替尼展现同类最优潜力_第3页
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
一线CLL/SLL持续治疗方案III期临床数据(非头对头对比):泽布替尼展现同类最优潜力_第4页
fCDlgqzljJbliYIgICAgICAgfCDml7bpl7QgICAgICAgfAp8LS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tfAp8IENESzTmipHliLbliYIgICB8IDIwMjVIMSAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8IEI3LUg0IEFEQyAgICB8IDIwMjVIMSAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjYgICAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8IEI3LUgzIEFEQyAgICB8IDIwMjVIMiAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjVIMiAgICAgfAp8IFBSTVQ1K01BVDJBICB8IDIwMjYgICAgICAgfAp8ICAgICAgICAgICAgICB8IDIwMjYgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45ryU56S65p2Q5paZ77yM5Zu96YeR6K+B5Yi456CU56m25omA
一线CLL/SLL持续治疗方案III期临床数据(非头对头对比):泽布替尼展现同类最优潜力_第5页
fCDntKLmiZjlhYvmi4kgIHwgIFIvUiBNQ0wgMiB8IDIwMjVIMiB8CnwtLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS18LS0tLS0tLS0tfAp8IEJUSyBDREFDIHwgMUwgRVNDQyAgICAgfCAyMDI1SDEgIHwKfCDmm7/pm7fliKnnj6DljZXmipcgfCAxTCBHQyAzICAgICB8IDIwMjVIMiAgfAp8ICvmm7/pm7fliKnnj6DljZXmipcgfCBIRVJJWk9OLTMwMSAxTCBIRVIyK0dFQSAzIOacn+aVsOaNruivu+WHuiB8IDIwMjVIMiAgfAp8IOWhlOaLieWmpeWNleaKlyB8ICAgICAgICAgICAgIHwgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrlhazlj7jmvJTnpLrmnZDmlpnvvIzlm73ph5Hor4HliLjnoJTnqbbmiYA=
所属报告: 百济神州(6160.HK)-港股公司研究报告:龙头Biopharma高举高打商业化和研发迎收获期-250805(31页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠